Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan in PNH Patients with Inadequate Response to Eculizumab
NCT03030183Phase 2Completed
- Sponsor
- Ra Pharmaceuticals
- Start
- Apr 2017
- Primary completion
- Mar 2018
- Modality
- Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of zilucoplan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Ra Pharmaceuticals. Started Apr 2017; status: completed.
02
Drugs
zilucoplan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT03030183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030183.